Stay updated on Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Sign up to get notified when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.

Latest updates to the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page
- Check6 days agoChange DetectedRevision entry added: v3.5.2. Previous entry v3.5.0 was removed from the history.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision v3.5.0 has been added and revision v3.4.3 has been removed.SummaryDifference0.1%

- Check42 days agoChange DetectedRevision history shows an addition of revision v3.4.3 and a deletion of revision v3.4.2 from the record history.SummaryDifference0.1%

- Check49 days agoChange DetectedStudy Status and Recruitment Status were updated to Active, not recruiting, and the Contacts/Locations section was added/updated in the latest version (v43) with the dates 2026-03-03 and 2026-03-04.SummaryDifference0.4%

- Check71 days agoChange DetectedRevision: v3.4.2 was added, the previous v3.4.1 revision label and a government-funding notice banner were removed; these are minor site maintenance/versioning updates that do not alter study details or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check78 days agoChange DetectedNew site notice about government funding lapse and open status is displayed at the top of the page, and the history now shows Revision: v3.4.1 replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Gilteritinib Combo for Newly Diagnosed AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gilteritinib Combo for Newly Diagnosed AML Clinical Trial page.